


The investment objective of the Fund is to achieve long-term capital growth through investment in a diversified portfolio of global quoted equity investments.
| Name | % Net Assets |
|---|---|
| US 30 Year Treasury Bond | 9.3% |
| Altria | 6.9% |
| Lorillard | 6.2% |
| Imperial Tobacco | 5.1% |
| British American Tobacco | 5.1% |
| Philip Morris International | 4.8% |
| Terra Nitrogen | 4.1% |
| Koninklijke KPN | 3.4% |
| Roche | 3.1% |
| BHP Billiton | 3.1% |
| Key | % Net Assets |
|---|---|
| 9.3% | |
| 6.9% | |
| 6.2% | |
| 5.1% | |
| 72.5% |
| Date | 23-Nov-2017 |
|---|---|
| NAV | 1.26p |
| Currency | GBP |
| Change | 0.000p |
| % | -0.01% |
| YTD change | 1.26p |
| YTD % | n/a |
| Fund Inception | 01/07/2008 |
|---|---|
| Fund Manager | n/a |
| Minimum Investment | |
|---|---|
| Initial | £2000000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.25% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research